Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

4.4K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
4.4K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

10.7K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.7K
Bone Formation by Endochondral Ossification01:24

Bone Formation by Endochondral Ossification

10.2K
Bone formation, or ossification, begins around the sixth to seventh week of embryonic development. Most bones develop from a cartilaginous template through the process of endochondral ossification. Cartilage formation begins when clusters of mesenchymal cells differentiate into chondrocytes. These chondrocytes proliferate rapidly and secrete an extracellular matrix that becomes encased in a membrane called the perichondrium. The resulting cartilage model provides a template that resembles the...
10.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Expression of Phosphomimetic OSTM1-T328E/S329D Variant Partially Restores Bone Resorption Defect in LRRK1-Deficient Mice.

Biology·2026
Same author

Evaluation of the Osteogenic Potential of a NOTCH1 Agonist and Poloxamer 407 Hydrogel Regarding Osteoblasts.

Biology·2026
Same author

Enhanced Bone Formation in Segmental Defect Healing Using 3D Printed Scaffolds Containing Bone Marrow Stromal Cells and Small Molecules Targeting Chondrogenesis and Osteogenesis.

Biomedicines·2026
Same author

Leucine-Rich Repeat Kinase 1 Signaling Targets Proteins Critical for Endosome/Lysosome Sorting and Trafficking in Osteoclasts.

Biology·2025
Same author

FAM98 Family Proteins Play Distinct Roles in Osteoclastogenesis and Bone Resorption.

Biology·2025
Same author

An In Vitro Orbital Flow Model to Study Mechanical Loading Effects on Osteoblasts.

Biology·2024

Related Experiment Video

Updated: Feb 27, 2026

Real-time Analyses of Retinol Transport by the Membrane Receptor of Plasma Retinol Binding Protein
14:32

Real-time Analyses of Retinol Transport by the Membrane Receptor of Plasma Retinol Binding Protein

Published on: January 28, 2013

14.2K

Retinol Binding Protein 4 Promotes Chondrocyte and Osteoclast Differentiation.

Adam Quincey1, Subburaman Mohan1,2,3,4, Bouchra Edderkaoui1,2

  • 1Musculoskeletal Disease Center, Research Service, VA Loma Linda Healthcare Systems, Loma Linda, CA 92357, USA.

Biology
|February 26, 2026
PubMed
Summary

Retinol-binding protein 4 (RBP4) drives inflammation and insulin resistance, impacting cartilage and bone. Inhibiting RBP4 may offer a new therapeutic strategy for osteoarthritis, especially in metabolic conditions.

Keywords:
chondrocytefenretinideosteoclastretinol-binding protein 4

More Related Videos

Author Spotlight: Unraveling Vitamin A Transport Mechanisms — Linking Liver Receptors to Vision Health Through RBPR2 and RBP4 Interactions
08:18

Author Spotlight: Unraveling Vitamin A Transport Mechanisms — Linking Liver Receptors to Vision Health Through RBPR2 and RBP4 Interactions

Published on: October 4, 2024

1.5K
Author Spotlight: Investigating Physiological Functions of Vitamin A Transporters Using HPLC-Based Vitamin A Profiling
05:03

Author Spotlight: Investigating Physiological Functions of Vitamin A Transporters Using HPLC-Based Vitamin A Profiling

Published on: December 27, 2024

1.7K

Related Experiment Videos

Last Updated: Feb 27, 2026

Real-time Analyses of Retinol Transport by the Membrane Receptor of Plasma Retinol Binding Protein
14:32

Real-time Analyses of Retinol Transport by the Membrane Receptor of Plasma Retinol Binding Protein

Published on: January 28, 2013

14.2K
Author Spotlight: Unraveling Vitamin A Transport Mechanisms — Linking Liver Receptors to Vision Health Through RBPR2 and RBP4 Interactions
08:18

Author Spotlight: Unraveling Vitamin A Transport Mechanisms — Linking Liver Receptors to Vision Health Through RBPR2 and RBP4 Interactions

Published on: October 4, 2024

1.5K
Author Spotlight: Investigating Physiological Functions of Vitamin A Transporters Using HPLC-Based Vitamin A Profiling
05:03

Author Spotlight: Investigating Physiological Functions of Vitamin A Transporters Using HPLC-Based Vitamin A Profiling

Published on: December 27, 2024

1.7K

Area of Science:

  • Biochemistry
  • Cell Biology
  • Molecular Biology

Background:

  • Retinol-binding protein 4 (RBP4) is an adipokine linked to metabolic inflammation and insulin resistance.
  • Type 2 diabetes (T2D), a risk factor for osteoarthritis, shares characteristics of chronic low-grade inflammation with joint degeneration.
  • The study explores the role of RBP4 in joint-related cells under inflammatory and metabolic stress.

Purpose of the Study:

  • To investigate how inflammatory and metabolic stresses regulate RBP4 expression and function in chondrocytes.
  • To examine the effect of RBP4 inhibition on chondrogenic differentiation and catabolic responses.
  • To assess the impact of RBP4 inhibition on osteoclastogenesis.

Main Methods:

  • Utilized murine immature chondrocyte cells (iMACs) and ATDC5 cells as in vitro chondrocyte models.
  • Stimulated ATDC5 cells with interleukin-6 (IL-6) and high glucose.
  • Administered fenretinide (FEN), an RBP4 inhibitor, to chondrocytes and RAW 264.7 macrophage cells.

Main Results:

  • Rbp4 mRNA expression increased during chondrocyte differentiation and upon IL-6 stimulation.
  • FEN treatment attenuated chondrogenic differentiation, reduced glycosaminoglycan synthesis, and mitigated high-glucose-induced catabolic responses.
  • FEN significantly reduced osteoclast differentiation markers in RAW 264.7 cells.

Conclusions:

  • RBP4 acts as a metabolic-inflammatory mediator affecting cartilage and bone remodeling.
  • RBP4 plays a role in regulating osteoclast-associated pathways.
  • Targeting RBP4 presents a potential therapeutic strategy for osteoarthritis, particularly in metabolic disorders.